MDS Abstracts

Abstracts from the International Congress of Parkinson’s and Movement Disorders.

MENU 
  • Home
  • Meetings Archive
    • 2025 International Congress
    • 2024 International Congress
    • 2023 International Congress
    • 2022 International Congress
    • MDS Virtual Congress 2021
    • MDS Virtual Congress 2020
    • 2019 International Congress
    • 2018 International Congress
    • 2017 International Congress
    • 2016 International Congress
  • Keyword Index
  • Resources
  • Advanced Search

Articles tagged "Parkinsonism"

  • MDS Virtual Congress 2020

    Psychiatric comorbidities in Young Onset Parkinson’s disease

    A. Patwardhan, P. Pal, N. Kamble, R. Yadav (Bangalore, India)

    Objective: The study aims at exploring psychiatric comorbities;namely;anxiety,depression and impulse control disorders(ICD) and their inter relationship in a large cohort of Young onset PD(YOPD)patients. Background:…
  • MDS Virtual Congress 2020

    Safety and efficacy of istradefylline, an adenosine A2A receptor antagonist, as a function of baseline dyskinesia (BL-dyskinesia) in Parkinson’s disease (PD): A pooled analysis of 4 studies

    L. Elmer, K. Toyama, J. Parno, D. Braccia, R. Ristuccia, A. Mori (Toledo, OH, USA)

    Objective: To evaluate the effect of BL-dyskinesia on the efficacy and safety of istradefylline in 4 randomized, placebo-controlled, double-blind, phase 2b/3 trials. Background: Istradefylline, a…
  • MDS Virtual Congress 2020

    Interpretation of health-related quality of life outcomes from the EARLYSTIM Study

    P. Martinez-Martin, G. Deuschl, L. Tonder, A. Schnitzler, J.L Houeto, J. Rau, C. Schade-Brittinger, V. Stoker, M. Vidailhet, P. Krack (Madrid, Spain)

    Objective: To conduct a secondary analysis of the EARLYSTIM study1 to 1: Quantify the meaning of HRQoL outcomes and 2: Evaluate the changes of disease…
  • MDS Virtual Congress 2020

    Apomorphine Sublingual Film for On-Demand Treatment of “OFF” Episodes in Patients With Parkinson’s Disease: Effect on MDS-UPDRS Part III Subdomains

    M. Siddiqui, V. Evidente, P. Bhargava, B. Navia, E. Pappert (Winston-Salem, NC, USA)

    Objective: Evaluate effect of apomorphine sublingual film (APL-130277; APL) as an on-demand treatment of “OFF” episodes in patients with Parkinson’s disease (PD) on MDS-UPDRS Part…
  • MDS Virtual Congress 2020

    Can we customize tune for asymmetric tremor with differentiated Deep brain stimulation frequencies?

    G. Baille, A. Kreisler, G. Touzet, L. Defebvre, D. Devos, C. Moreau (Lille, France)

    Objective: We aimed to display if differentiated frequency can improve the tremor in patients with STN-DBS. Background: Subthalamic deep brain stimulation (STN-DBS) is the best…
  • MDS Virtual Congress 2020

    The Indian Experience of Continuous Dopaminergic therapy with Apomorphine in Parkinson’s Disease

    D. Hoskere Sreenivasa, R. Jayachandran, R. Seetharam, R. Iyer, P. Kukkle (Bangalore, India)

    Objective: A clinical audit of apomorphine pumps – The Indian experience. Background: Continuous dopaminergic therapy remains crucial in the management of moderately advanced Parkinson’s disease…
  • MDS Virtual Congress 2020

    Neuroprotective and neuromodulatory properties of Olea purpurea leaf extract in MPTP intoxicated Parkinsonian rat model

    A. Singh, T. Yadav, A. Pandey (Allahabad, India)

    Objective: This study aimed to isolate and characterize Olea purpurea leaf extract, and its neuroprotective effect in MPTP induced parkinsonian rat model. Background: Parkinson's disease (PD), also…
  • MDS Virtual Congress 2020

    FDG-PET degeneration patterns predict amyloid deposition in Corticobasal Syndrome

    J. Parmera, A. Coutinho, A. Neto, C. Ono, M. Aranha, C. Buchpiguel, R. Nitrini, E. Barbosa, S. Brucki (Sao Paulo, Brazil)

    Objective: To investigate if an individual clinically-focused analysis of brain FDG-PET metabolic patterns and a comprehensive neurological evaluation could distinguish Corticobasal Syndrome (CBS) pathological variants…
  • MDS Virtual Congress 2020

    Intracranial Tuberculous Abcess with Acute Parkinsonism: Unusual Finding

    KK. Shahedah, A.A Nurul Asyikin (Kuala Lumpur, Malaysia)

    Objective: A case report of central nervous system (CNS) tuberculosis infection with acute parkinsonism. Background: Neurotuberculosis is a recognized clinical entity which can present with…
  • MDS Virtual Congress 2020

    A sensor-based analysis of freezing of turning in bed: A new manifestation of nocturnal hypokinesia

    J. Sringean, C. Anan, C. Thanawattano, R. Bhidayasiri (Bangkok, Thailand)

    Objective: To identify characteristics of freezing of turning in bed in PD patients using an axial inertial sensor (NIGHT-Recorder®) and synchronous video recording. Background: Freezing…
  • « Previous Page
  • 1
  • …
  • 90
  • 91
  • 92
  • 93
  • 94
  • …
  • 405
  • Next Page »

Most Viewed Abstracts

  • This Month
  • All Time
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • Life expectancy with and without Parkinson’s disease in the general population
  • #24970 (not found)
  • Increased Risks of Botulinum Toxin Injection in Patients with Hypermobility Ehlers Danlos Syndrome: A Case Series
  • To be or not to bupropion: a drug-induced parkinsonism?
    • Help & Support
    • About Us
    • Cookies & Privacy
    • Wiley Job Network
    • Terms & Conditions
    • Advertisers & Agents
    Copyright © 2026 International Parkinson and Movement Disorder Society. All Rights Reserved.
    Wiley